- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06250088
Emdogain Adjunctive to Autotransplantation (ATTEMD)
May 7, 2024 updated by: Ignacio Pedrinaci Peñalver, Universidad Complutense de Madrid
Efficacy of Enamel Matrix Derivatives Adjunctive to Closed-apex Teeth Autotransplantation A Randomized Clinical Trial
The goal of this randomized clinical trial is to compare the adjunctive use of enamel matrix derivatives in the treatment of tooth autotransplantation in terms of clinical attachment level.
The main question it aims to answer.
What is the benefit, in terms of clinical attachment level and probing depths, of using enamel matrix derivatives adjunctive to tooth autotransplantation? Participants will be subjected to a digitally guided surgery of tooth autotransplantation.
The protocol of the test group will be supplemented with the application of enamel matrix derivatives before the placement of the transplanted tooth into the surgically produced alveolus.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28003
- Recruiting
- Universidad Complutense de Madrid
-
Contact:
- Ignacio Pedrinaci
- Phone Number: +34 656257658
- Email: ipedrinaci@gmail.com
-
Principal Investigator:
- Ignacio Pedrinaci
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria: Adult patients attending the University Complutense of Madrid for dental treatment were eligible to participate in the study if they met the following criteria:
- adults (≥18 years old) capable of providing informed consent, teeth deemed-unrestorable in need of replacement
- presence of a viable, healthy, periodontally stable, and nonfunctional tooth (e.g., third molar) suitable for autotransplantation
- periodontally healthy individuals or those with stable periodontal conditions after periodontal therapy.
Exclusion Criteria:
- clinical attachment loss of the donor teeth (CAL less 6 mm)
- compromised general health or patients with systemic diseases that could influence the therapy outcome (uncontrolled diabetes mellitus, bone disorders, etc.)
- pregnant or nursing women
- chronic use of corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or immune-modulator drugs
- patients requiring medications that affect bone metabolism (bisphosphonates
- chronic oral mucosa diseases
- evident signs of severe bruxism or clenching habits
- smokers of more than 10 cigarettes per day
- non-compliant patients with 25% plaque index at the time of re-evaluation after non-surgical periodontal therapy and oral hygiene instructions
- patients unable to attend study-related procedures and follow-up visits
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Control
|
Initially, tooth sectioning of the hopeless tooth (receptor) will be carried out using fissure carbide burs, and the resulting two fragments will be extracted with a minimally invasive approach.
A multiple drilling axis tooth-supported surgical guide will be used to prepare the recipient site in accordance with the 3D planning.
Additional alveoloplasty procedures will be performed with round diamond burs if necessary to adapt thecomputer assisted rapid prototyping (CARP) model to the virtual planning position.
The donor tooth will be extracted as atraumatically as possible, utilizing a piezoelectric surgical instrument if ostectomy is required, and avoiding the use of elevators or forceps over the root surface.
No Emdodain (EMD).
Sutures will be applied to closely adapt the soft tissues around the autotransplanted tooth.
A semi-rigid orthodontic wire will be used to splint the tooth to the mesial and distal adjacent teeth
|
Active Comparator: Emdogain (EMD)
|
Initially, tooth sectioning of the hopeless tooth (receptor) will be carried out using fissure carbide burs, and the resulting fragments will be extracted with a minimally invasive approach.
A multiple drilling axis tooth-supported surgical guide will be used to prepare the recipient site in accordance with the 3D planning.
Additional alveoloplasty procedures will be performed with round diamond burs if necessary to adapt the computer assisted rapid prototyping (CARP) model to the virtual planning position.
The donor tooth will be extracted as atraumatically as possible, utilizing a piezoelectric if ostectomy is required, and avoiding the use of elevators or forceps over the root surface.
Extraorally, (Emdogain) EMD will be applied to the root surface of the donor tooth.
Sutures will be applied to closely adapt the soft tissues around the autotransplanted tooth.
A semi-rigid orthodontic wire will be used to splint the tooth to the mesial and distal adjacent teeth
Initially, tooth sectioning of the hopeless tooth (receptor) will be carried out using fissure carbide burs, and the resulting two fragments will be extracted with a minimally invasive approach.
A multiple drilling axis tooth-supported surgical guide will be used to prepare the recipient site in accordance with the 3D planning.
Additional alveoloplasty procedures will be performed with round diamond burs if necessary to adapt thecomputer assisted rapid prototyping (CARP) model to the virtual planning position.
The donor tooth will be extracted as atraumatically as possible, utilizing a piezoelectric surgical instrument if ostectomy is required, and avoiding the use of elevators or forceps over the root surface.
No Emdodain (EMD).
Sutures will be applied to closely adapt the soft tissues around the autotransplanted tooth.
A semi-rigid orthodontic wire will be used to splint the tooth to the mesial and distal adjacent teeth
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical Attachment Level
Time Frame: through study completion, an average of 1 year
|
measured as the distance in mm from the CEJ to the bottom of the pocket will be the primary outcome of this study.
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Radiographic bone level
Time Frame: through study completion, an average of 1 year
|
Changes in marginal bone levels (MBLs), measured as the change in interproximal bone levels between 4 weeks after autotransplantation, six months and one year postoperatively.
MBLs are defined as the distance between the cementoenamel junction (CEJ) and to the crestal bone level at the mesial and distal aspect .
These measurements will also be recorded at the adjacent teeth/implants.
For standardization of the radiographic technique, a customized bite block will be constructed for each patient using a parallel technique X-ray film holder (i.e.Rinn System, x-ray system or similar) and heavy silicone.
The obtained digital radiographs will be evaluated using the image software (OsiriX Imaging Software, Geneva, Switzerland), with previous calibration of the images by inserting a small metal object of known measures in the bite block
|
through study completion, an average of 1 year
|
Digital image assessment. Position of the Alveolar Ridge Measurements
Time Frame: at the study completion. an average of 1 year
|
For each patient, the baseline and the last follow-up visit STL files and Digital Imaging and Communications in Medicine (DICOM) files will be superimposed for best-fit alignment.
Alveolar ridge width changes will also be evaluated at the buccal and lingual mesial, mid, and distal sites.
A sagittal section at each area of interest will be made.
Horizontal alveolar ridge width linear changes will be quantified in mm at three predetermined reference points established at 1, 3, and 5mm from the baseline gingival margin.
|
at the study completion. an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 12, 2024
Primary Completion (Estimated)
June 1, 2025
Study Completion (Estimated)
March 1, 2026
Study Registration Dates
First Submitted
January 23, 2024
First Submitted That Met QC Criteria
January 31, 2024
First Posted (Actual)
February 8, 2024
Study Record Updates
Last Update Posted (Actual)
May 9, 2024
Last Update Submitted That Met QC Criteria
May 7, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- ATT_EMD_RCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autologous Transplantation
-
Emory UniversityGenzyme, a Sanofi CompanyCompleted
-
TME Pharma AGGerman Federal Ministry of Education and ResearchCompleted
-
Tel-Aviv Sourasky Medical CenterSanofiUnknownAutologous Stem Cell Transplantation
-
Aula Dental AvanzadaCompletedSurgery, Oral | Transplantation, Autologous | AutograftsSpain
-
University Hospital, GenevaRecruitingAllogeneic Hematopoietic Stem Cell Transplantation | Hematopoietic Stem Cell Transplantation | Autologous Hematopoietic Stem Cell TransplantationSwitzerland
-
Yicheng MaRecruitingAutologous Epidermal Cell TransplantationChina
-
University of CalgaryAlberta Children's HospitalTerminatedCancer | Autologous Hematopoietic Stem Cell TransplantationCanada
-
Tongji HospitalUnknownParathyroid Autologous TransplantationChina
-
Center for International Blood and Marrow Transplant...RecruitingAllogeneic Stem Cell Transplantation | Autologous Stem Cell Transplantation | Cellular Therapy | Marrow Toxic InjuryUnited States
-
Imperial College LondonWithdrawnAllogeneic Stem Cell Transplantation | CMV Reactivation | Autologous CMV Specific CD8+ T CellsUnited Kingdom
Clinical Trials on Emdogain (EMD) - test
-
Tabriz UniversityCompletedGingival RecessionIran, Islamic Republic of
-
University of BelgradeActive, not recruitingSurgical Wound, Healed | Post Operative PainSerbia
-
University of Campinas, BrazilCompleted
-
University of BernCompleted
-
T.C. Dumlupınar ÜniversitesiCompletedBone Density Increased | Osseointegration Failure of Dental ImplantTurkey
-
Institut Straumann AGTerminated
-
Aristotle University Of ThessalonikiRecruitingPeriodontal Diseases | Furcation Defects | Periodontal Disease, AVDC Stage 3 | Periodontal Disease, AVDC Stage 4Greece
-
Institut Straumann AGTerminatedPeriodontal Diseases | Periodontal Attachment LossUnited States
-
Assistance Publique - Hôpitaux de ParisTerminated
-
Medical University of WarsawRecruitingPeriodontitis | RegenerationPoland